• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on April 28, 2026

    4/23/26 8:35:00 AM ET
    $BLTE
    $HCM
    $LOT
    $RADX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BLTE alert in real time by email

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Tuesday, April 28, 2026 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States.

    Representatives from participating companies based in Australia, China, Hong Kong, Portugal, Netherlands, Cayman Islands and France, will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies.

    There is no fee for participants to log in, attend live presentations and/or ask questions.

    Pre-registration is suggested. Please register here: www.adr.db.com/dbvic

    Conference Agenda April 28, 2026 (US Eastern Standard Time):

    • 8:00 AM: Lotus Technology Inc. (NASDAQ:LOT) 
    • 8:30 AM: Viomi Technology Co., Ltd (NASDAQ:VIOT)
    • 9:00 AM: Belite Bio, Inc  (NASDAQ:BLTE)
    • 9:30 AM: First Pacific Company Ltd ((HKEX: 142, OTC:FPAFY)
    • 10:00 AM: HUTCHMED (China) Limited (AIM: HCM, NASDAQ:HCM, and HKEX:13)
    • 10:30 AM: HEINEKEN (OTCQX:HEINY, Euronext Amsterdam: HEIA)) 
    • 11:00 AM: Yiren Digital Ltd. (NYSE:YRD)
    • 11:30 AM: Carrefour (PARIS:CA, OTC:CRRFY) 
    • 12:00 PM: Radiopharm Theranostics (NASDAQ:RADX, ASX: RAD)) 
    • 12:30 PM: WeRide (NASDAQ:WRD, HKEX: 0800))

    The presentations will be available for replay after the conference.

    In addition to specializing in administering cross-border equity structures such as American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. The Bank offers a broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.

    For further information, please contact:

    Dylan Riddle

    Deutsche Bank AG

    Press & Media Relations

    Tel. +12122504982

    Cell. +1(904)3866481

    Email dylan.riddle@db.com

    Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany's leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.

    Deutsche Bank is sponsoring the Deutsche Bank Depositary Receipt Investor Conference solely for informational purposes. Deutsche Bank does not prepare, review, approve or edit any presentations, statements, documents or other information or materials, whether in written, electronic or verbal form, provided by any company participating in such conference, and disclaims any responsibility for the accuracy or adequacy of any such information or materials. Deutsche Bank is not promoting, endorsing or recommending any company participating in the conference.

    The Depositary Receipts have been registered pursuant to the US Securities Act of 1933 (the "Act") on Form F-6. The investment or investment service which is the subject of this notice is not available to retail clients as defined by the UK Financial Conduct Authority. This notice has been approved and/or communicated by Deutsche Bank AG New York. The services described in this notice are provided by Deutsche Bank Trust Company Americas (Deutsche Bank) or by its subsidiaries and/or affiliates in accordance with appropriate local registration and regulation. Deutsche Bank is providing the attached notice strictly for information purposes and makes no claims or statement, nor does it warrant as to or guarantee the accuracy or completeness of the details contained herein and does not undertake an obligation to update or amend this information. Deutsche Bank, its subsidiaries and/or affiliates disclaims any and all liability to fullest extent permitted by law, whether arising in tort, contract or otherwise, which any of them might otherwise have in respect of the above information. This announcement appears as a matter of record only. Neither this announcement nor the information contained herein constitutes an offer or solicitation by Deutsche Bank or any other issuer or entity for the purchase or sale of any securities in the United States, nor does it constitute an offer or solicitation to any person in any other jurisdiction. No part of this notice may be copied or reproduced in any way without the prior written consent of Deutsche Bank. Past results are not an indication of future performance. Copyright© April 2026 Deutsche Bank AG. All rights reserved.



    Primary Logo

    Get the next $BLTE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BLTE
    $HCM
    $LOT
    $RADX

    CompanyDatePrice TargetRatingAnalyst
    Radiopharm Theranostics Limited
    $RADX
    6/4/2026$6.00Buy
    H.C. Wainwright
    WeRide Inc.
    $WRD
    3/31/2026$11.40Buy
    HSBC Securities
    WeRide Inc.
    $WRD
    3/26/2026$11.00Outperform
    BNP Paribas Exane
    WeRide Inc.
    $WRD
    2/10/2026$17.50Outperform
    Macquarie
    Belite Bio Inc
    $BLTE
    1/26/2026$195.00Buy
    BofA Securities
    Belite Bio Inc
    $BLTE
    1/6/2026$191.00Overweight
    Morgan Stanley
    WeRide Inc.
    $WRD
    1/5/2026$13.00Outperform
    CLSA
    Belite Bio Inc
    $BLTE
    12/2/2025$194.00Neutral → Outperform
    Mizuho
    More analyst ratings

    $BLTE
    $HCM
    $LOT
    $RADX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Scholl Hendrik Peter sold $1,452,435 worth of American depositary share (10,000 units at $145.24) (SEC Form 4)

    4 - BELITE BIO, INC (0001889109) (Issuer)

    6/22/26 6:05:45 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Scholl Hendrik Peter sold $1,405,729 worth of American depositary share (10,000 units at $140.57) (SEC Form 4)

    4 - BELITE BIO, INC (0001889109) (Issuer)

    6/17/26 6:03:33 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Executive Chairman and CEO Tang Ning acquired 81,176,519 units of Ordinary Shares (SEC Form 4)

    4 - Yiren Digital Ltd. (0001631761) (Issuer)

    6/8/26 8:12:59 PM ET
    $YRD
    Finance: Consumer Services
    Finance

    $BLTE
    $HCM
    $LOT
    $RADX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on Radiopharm Theranostics with a new price target

    H.C. Wainwright initiated coverage of Radiopharm Theranostics with a rating of Buy and set a new price target of $6.00

    6/4/26 8:45:49 AM ET
    $RADX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HSBC Securities initiated coverage on WeRide with a new price target

    HSBC Securities initiated coverage of WeRide with a rating of Buy and set a new price target of $11.40

    3/31/26 10:45:27 AM ET
    $WRD
    EDP Services
    Technology

    BNP Paribas Exane initiated coverage on WeRide with a new price target

    BNP Paribas Exane initiated coverage of WeRide with a rating of Outperform and set a new price target of $11.00

    3/26/26 8:52:50 AM ET
    $WRD
    EDP Services
    Technology

    $BLTE
    $HCM
    $LOT
    $RADX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Yiren Digital Reports First Quarter 2026 Unaudited Financial Results

    BEIJING, June 25, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Operational ResultsCredit Solution BusinessTotal loans facilitated in the first quarter of 2026 were RMB8.9 billion (US$1.3 billion), representing a decrease of 26% compared to RMB12.0 billion in the fourth quarter of 2025, and a decrease of 42% compared to RMB15.2 billion in the same period of 2025.Number of borrowers served in the fi

    6/25/26 7:00:00 AM ET
    $YRD
    Finance: Consumer Services
    Finance

    WeRide GENESIS Named “Generative AI Platform of the Year,” Following ATTI Simulation Innovation Award

    WeRide GENESIS received two major industry awards within days, including the 2026 ATTI Simulation Innovation Award and "Overall Gen-AI Solution of the Year" at the 2026 AI Breakthrough Awards.Physical AI world model enables large-scale autonomous driving simulation, training, and validation.Reduces autonomous driving data collection and annotation costs by more than 75%.Powers WRD 3.0, WeRide’s end-to-end ADAS solution, supporting global commercialization and deployment. GUANGZHOU, China, June 25, 2026 (GLOBE NEWSWIRE) -- WeRide (NASDAQ:WRD, HKEX: 0800)), a global autonomous driving technology company, announced today that its proprietary world model, WeRide GENESIS, has been named "Overa

    6/25/26 6:25:37 AM ET
    $WRD
    EDP Services
    Technology

    HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026

    — Registration-enabling study demonstrated high clinically meaningful objective responses, achieving rapid and durable disease control — — Fanregratinib holds promise as a new treatment option for pretreated advanced ICC patients harboring FGFR2-fusions/rearrangements — HONG KONG and FLORHAM PARK, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces results from the pivotal Phase II registration study of fanregratinib (HMPL-453) in patients with intrahepatic cholangiocarcinoma ("ICC") will be presented at the European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress taking place from July 1 to 4, 2026

    6/24/26 8:00:00 PM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLTE
    $HCM
    $LOT
    $RADX
    SEC Filings

    View All

    SEC Form 6-K filed by Yiren Digital Ltd.

    6-K - Yiren Digital Ltd. (0001631761) (Filer)

    6/26/26 7:00:03 AM ET
    $YRD
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by HUTCHMED (China) Limited

    6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

    6/25/26 6:06:25 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Lotus Technology Inc.

    6-K - Lotus Technology Inc. (0001962746) (Filer)

    6/15/26 6:02:04 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    $BLTE
    $HCM
    $LOT
    $RADX
    Financials

    Live finance-specific insights

    View All

    Yiren Digital Reports First Quarter 2026 Unaudited Financial Results

    BEIJING, June 25, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Operational ResultsCredit Solution BusinessTotal loans facilitated in the first quarter of 2026 were RMB8.9 billion (US$1.3 billion), representing a decrease of 26% compared to RMB12.0 billion in the fourth quarter of 2025, and a decrease of 42% compared to RMB15.2 billion in the same period of 2025.Number of borrowers served in the fi

    6/25/26 7:00:00 AM ET
    $YRD
    Finance: Consumer Services
    Finance

    Yiren Digital to Report First Quarter 2026 Financial Results on June 25, 2026

    BEIJING, June 17, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced that it plans to release its unaudited financial results for the first quarter ended March 31, 2026 before U.S. market opens on Thursday, June 25, 2026. Yiren Digital's management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on June 25, 2026 (or 8:00 p.m. Beijing/Hong Kong Time on June 25, 2026).Participants who wish to join the call should register online in advance of the conference at: https://dpregist

    6/17/26 5:00:00 AM ET
    $YRD
    Finance: Consumer Services
    Finance

    WRD 3.0 Becomes China's First Four-Time Urban Intelligent Driving Champion, WeRide Reports Record Q1 2026 Revenue, up 58% Year over Year

    NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. ("WeRide" or the "Company") (NASDAQ:WRD, HKEX: 0800)), a global leader in autonomous driving technology, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Total revenue was RMB114.1 million (US$16.5 million), representing an increase of 57.6% year over year. Product revenue was RMB20.5 million (US$3.0 million), representing an increase of 115.8% year over year, primarily attributable to increased revenue from robotaxi and other L4 vehicle sales.Service revenue was RMB93.7 million (US$13.6 million), representing an increase of 49.0% year over year. Gross

    5/13/26 5:40:00 AM ET
    $WRD
    EDP Services
    Technology

    $BLTE
    $HCM
    $LOT
    $RADX
    Leadership Updates

    Live Leadership Updates

    View All

    Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update

    Initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); submission expected to be completed in the second quarter of 2026Commercialization preparation for STGD1 underway; hiring of all key commercial leadership positions completed Cash and cash equivalents, U.S. treasury bills and notes: $798.6 million as of March 31, 2026Conference call and webcast on Wednesday, May 20, 2026, at 4:30 p.m. ET SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing nov

    5/20/26 6:00:00 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LOTUS Appoints Piano Master Lang Lang as Friend of the Brand

    NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus Tech" or the "Company") (NASDAQ:LOT), a leading global intelligent and luxury mobility provider, today updated that LOTUS announced world-renowned pianist Lang Lang as its Friend of the Brand, marking a new partnership built on a shared pursuit of precision, performance, and excellence. Recognized globally for his extraordinary technique and expressive artistry, Lang Lang has brought classical music to audiences across cultures and generations. His dedication to mastery through discipline and refinement closely mirrors LOTUS's engineering philosophy, where every detail is shaped to deliver pure driving performance.

    2/6/26 8:30:00 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    Viomi Technology Co., Ltd Appoints Malaysian Pop Star Shila Amzah as Brand Ambassador and Announces New AI Water Purifier Launch in Malaysia

    GUANGZHOU, China, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ:VIOT), a leading technology company for home water solutions in China, today announced the appointment of renowned Malaysian singer Ms. Shila Amzah as its brand ambassador in Malaysia. Ms. Amzah will join Viomi for a product launch event in Malaysia on October 30, where the Company will unveil its new AI water purifier, INNO, designed to bring a smarter and safer drinking water lifestyle to local households. Mr. Xiaoping Chen, Founder and CEO of Viomi, commented: "We are thrilled to welcome Ms. Shila Amzah as our brand ambassador in Malaysia. Together, at our upcoming product

    10/20/25 9:00:28 AM ET
    $VIOT
    Consumer Electronics/Appliances
    Consumer Discretionary

    $BLTE
    $HCM
    $LOT
    $RADX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Viomi Technology Co. Ltd

    SC 13G/A - Viomi Technology Co., Ltd (0001742770) (Subject)

    11/12/24 6:35:53 AM ET
    $VIOT
    Consumer Electronics/Appliances
    Consumer Discretionary

    SEC Form SC 13G filed by Lotus Technology Inc.

    SC 13G - Lotus Technology Inc. (0001962746) (Subject)

    11/12/24 6:07:58 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    SEC Form SC 13G filed by Lotus Technology Inc.

    SC 13G - Lotus Technology Inc. (0001962746) (Subject)

    11/8/24 6:04:35 AM ET
    $LOT
    Auto Manufacturing
    Industrials